chr6-33304131-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003190.5(TAPBP):c.1297G>A(p.Ala433Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,612,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003190.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAPBP | NM_003190.5 | c.1297G>A | p.Ala433Thr | missense_variant | 6/8 | ENST00000434618.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAPBP | ENST00000434618.7 | c.1297G>A | p.Ala433Thr | missense_variant | 6/8 | 1 | NM_003190.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151406Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250806Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135552
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461522Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727060
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151406Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73908
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.1297G>A (p.A433T) alteration is located in exon 6 (coding exon 6) of the TAPBP gene. This alteration results from a G to A substitution at nucleotide position 1297, causing the alanine (A) at amino acid position 433 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MHC class I deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1426651). This variant has not been reported in the literature in individuals affected with TAPBP-related conditions. This variant is present in population databases (rs765383234, gnomAD 0.003%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 433 of the TAPBP protein (p.Ala433Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at